Scleroderma;Progressive
1 clinical trials · Condition
◉ Watch Scleroderma;Progressive
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients (NCT04837131) | Michael M. Pham | 2021-04-28 |
Track Scleroderma;Progressive automatically
Every clearance here is in the API, with alerts when new ones post.